Raja Dhar

Dr. Raja Dhar


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2017 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
SSSheetu Singh
Sheetu Singh
BCBridget F. Collins
Bridget F. Collins
BSBharat B. Sharma
Bharat B. Sharma
JJJyotsna M. Joshi
Jyotsna M. Joshi
DTDeepak Talwar
Deepak Talwar
GRGanesh Raghu
Ganesh Raghu
Rationale: Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings. Little is known about the clinical profile of ILDs in India. Objectives: To characterize new-onset ILDs in India by creating a prospective ILD using multidisciplinary discussion (MDD) to validate diagnoses. Methods: Adult patients of Indian origin living in India with new-onset ILD (27 centers, 19 Indian cities, March 2012–June 2015) without malignancy or infection were included. All had connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tomography chest. ILD pattern was defined by high-resolution computed tomography images. Three groups independently made diagnoses after review of clinical data including that from prompted case report forms: local site investigators, ILD experts at the National Data Coordinating Center (NDCC; Jaipur, India) with MDD, and experienced ILD experts at the Center for ILD (CILD; Seattle, WA) with MDD. Cohen’s κ was used to assess reliability of interobserver agreement. Measurements and Main Results: A total of 1,084 patients were recruited. Final diagnosis: hypersensitivity pneumonitis in 47.3% (n = 513; exposure, 48.1% air coolers), CTD-ILD in 13.9%, and idiopathic pulmonary fibrosis in 13.7%. Cohen’s κ: 0.351 site investigator/CILD, 0.519 site investigator/NDCC, and 0.618 NDCC/CILD. Conclusions: Hypersensitivity pneumonitis was the most common new-onset ILD in India, followed by CTD-ILD and idiopathic pulmonary fibrosis; diagnoses varied between site investigators and CILD experts, emphasizing the value of MDD in ILD diagnosis. Prompted case report forms including environmental exposures in prospective registries will likely provide further insight into the etiology and management of ILD worldwide.

1 September 2019 in The Lancet Global Health
Verified
Journal Article
Open access
RDRaja Dhar
Raja Dhar
SSSheetu Singh
Sheetu Singh
DTDeepak Talwar
Deepak Talwar
MMMurali Mohan
Murali Mohan
STSurya Kant Tripathi
Surya Kant Tripathi
JCJames D. Chalmers
James D. Chalmers
Bronchiectasis is a common but neglected chronic lung disease. Most epidemiological data are limited to cohorts from Europe and the USA, with few data from low-income and middle-income countries. We therefore aimed to describe the characteristics, severity of disease, microbiology, and treatment of patients with bronchiectasis in India. The Indian bronchiectasis registry is a multicentre, prospective, observational cohort study. Adult patients (≥18 years) with CT-confirmed bronchiectasis were enrolled from 31 centres across India. Patients with bronchiectasis due to cystic fibrosis or traction bronchiectasis associated with another respiratory disorder were excluded. Data were collected at baseline (recruitment) with follow-up visits taking place once per year. Comprehensive clinical data were collected through the European Multicentre Bronchiectasis Audit and Research Collaboration registry platform. Underlying aetiology of bronchiectasis, as well as treatment and risk factors for bronchiectasis were analysed in the Indian bronchiectasis registry. Comparisons of demographics were made with published European and US registries, and quality of care was benchmarked against the 2017 European Respiratory Society guidelines. From June 1, 2015, to Sept 1, 2017, 2195 patients were enrolled. Marked differences were observed between India, Europe, and the USA. Patients in India were younger (median age 56 years [IQR 41-66] vs the European and US registries; p<0·0001]) and more likely to be men (1249 [56·9%] of 2195). Previous tuberculosis (780 [35·5%] of 2195) was the most frequent underlying cause of bronchiectasis and Pseudomonas aeruginosa was the most common organism in sputum culture (301 [13·7%]) in India. Risk factors for exacerbations included being of the male sex (adjusted incidence rate ratio 1·17, 95% CI 1·03-1·32; p=0·015), P aeruginosa infection (1·29, 1·10-1·50; p=0·001), a history of pulmonary tuberculosis (1·20, 1·07-1·34; p=0·002), modified Medical Research Council Dyspnoea score (1·32, 1·25-1·39; p<0·0001), daily sputum production (1·16, 1·03-1·30; p=0·013), and radiological severity of disease (1·03, 1·01-1·04; p<0·0001). Low adherence to guideline-recommended care was observed; only 388 patients were tested for allergic bronchopulmonary aspergillosis and 82 patients had been tested for immunoglobulins. Patients with bronchiectasis in India have more severe disease and have distinct characteristics from those reported in other countries. This study provides a benchmark to improve quality of care for patients with bronchiectasis in India. EU/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis Consortium, European Respiratory Society, and the British Lung Foundation.

19 April 2021 in Respirology
Verified
Journal Article
Open access
PDF file
Hyun LeeHyun Lee
Hyun Lee
HCHayoung Choi
Hayoung Choi
JCJames D. Chalmers
James D. Chalmers
RDRaja Dhar
Raja Dhar
TNTu Q. Nguyen
Tu Q. Nguyen
YOYeon-mok Oh
Yeon-mok Oh
Click on the article title to read more.

25 October 2024 in Chest
Verified
Journal Article
Closed access
JPJennifer Pollock
Jennifer Pollock
PGPieter C Goeminne
Pieter C Goeminne
SAStefano Aliberti
Stefano Aliberti
Eva PolverinoEva Polverino
Eva Polverino
MCMegan L. Crichton
Megan L. Crichton
MLMichael R. Loebinger
Michael R. Loebinger

1 July 2024 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
HCHayoung Choi
Hayoung Choi
JXJin-Fu Xu
Jin-Fu Xu
SCSanjay Haresh Chotirmall
Sanjay Haresh Chotirmall
JCJames D. Chalmers
James D. Chalmers
LMLucy Morgan
Lucy Morgan
RDRaja Dhar
Raja Dhar
Recent bronchiectasis studies from large-scale multinational, multicentre registries have demonstrated that the characteristics of the disease vary according to geographic region. However, most perspectives on bronchiectasis are dominated by data from Western countries. This review intends to provide an Asian perspective on the disease, focusing on the established registries in India, Korea and China. Asian patients with bronchiectasis are less likely to show female predominance and experience exacerbations, are more likely to be younger, have milder disease, and have fewer options for guideline-recommended treatment than those living in other global regions. Furthermore, Asian bronchiectasis patients demonstrate different comorbidities, microbiological profiles and unique endophenotypes, including post-tuberculosis and dry bronchiectasis. Notably, each Asian region reveals further geographic variations and inter-patient differences. Future studies are warranted to better characterise Asian patients with bronchiectasis.

4 September 2020 in Respirology
Verified
Journal Article
Open access
PDF file
RDRaja Dhar
Raja Dhar
MMMary Sau Man
Mary Sau Man
TKTarang Kulkarni
Tarang Kulkarni
SKSang-Heon Kim
Sang-Heon Kim
DPDiahn‐Warng Perng
Diahn‐Warng Perng
MKMariko Siyue Koh
Mariko Siyue Koh
Asthma imposes a significant burden on the health system and patients' quality of life. Within Asia, there is large variability in several cultural, social and economic factors ultimately influencing the management of asthma. Differences in risk factors and asthma management practices across Asia make asthma a truly ‘mixed‐bag’ phenomenon. With the advent of biological agents and the consequent emphasis on asthma phenotyping and endotyping, it is more important than ever to understand the diverse nature of asthma as a disease. This is a collaborative review within Asia to highlight the differences in management of adult asthma, and the local modifications that are made to international guidelines. This review paves the way for a future Asian collaborative network in asthma epidemiological research.